Real‐world impact of once‐weekly subcutaneous semaglutide after 2 years of follow‐up: Results from a nationwide observational study in people with type 2 diabetes
Vilsbøll, Tina, Lindahl, Caroline Ø., Nielsen, Nick F., Tikkanen, Christian K.
Published in Diabetes, obesity & metabolism (01.06.2023)
Published in Diabetes, obesity & metabolism (01.06.2023)
Get full text
Journal Article
The economic burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in Denmark
Lindvig, Asger, Tran, Martin Phuc, Kidd, Robert, Tikkanen, Christian K, Gæde, Peter
Published in Current medical research and opinion (03.06.2021)
Published in Current medical research and opinion (03.06.2021)
Get more information
Journal Article
Short-term societal economic burden of first-incident type 2 diabetes-related complications - a nationwide cohort study
Kjellberg, Jakob, Tikkanen, Christian K, Bagger, Malene, Gæde, Peter
Published in Expert review of pharmacoeconomics & outcomes research (01.11.2020)
Published in Expert review of pharmacoeconomics & outcomes research (01.11.2020)
Get more information
Journal Article
Clinical effectiveness of liraglutide vs basal insulin in a real‐world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes
Overbeek, Jetty A., Heintjes, Edith M., Huisman, Eline L., Tikkanen, Christian K., van Diermen, Arnout W., Penning‐van Beest, Fernie J.A., Herings, Ron M.C.
Published in Diabetes, obesity & metabolism (01.09.2018)
Published in Diabetes, obesity & metabolism (01.09.2018)
Get full text
Journal Article
Real‐world impact of once‐weekly subcutaneous semaglutide after 2years of follow‐up: Results from a nationwide observational study in people with type 2 diabetes
Vilsbøll, Tina, Lindahl, Caroline Ø, Nielsen, Nick F, Tikkanen, Christian K
Published in Diabetes, obesity & metabolism (01.06.2023)
Published in Diabetes, obesity & metabolism (01.06.2023)
Get full text
Journal Article